AJP - Heart Calcium Transients and Cell-Sarcomere
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Heart Circ Physiol 265: H267-H272, 1993;
0363-6135/93 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Berger, H. J.
Right arrow Articles by Halperin, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Berger, H. J.
Right arrow Articles by Halperin, J. A.

AJP - Heart and Circulatory Physiology, Vol 265, Issue 1 267-H272, Copyright © 1993 by American Physiological Society

ARTICLES

Activated complement directly modifies the performance of isolated heart muscle cells from guinea pig and rat

H. J. Berger, A. Taratuska, T. W. Smith and J. A. Halperin
Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115.

The complement system has been implicated in the pathogenesis of cardiovascular disorders including ischemia and atherosclerosis. Selective deposition of C5b-9, the membrane attack complex of complement, has been histochemically documented in human myocardium early after reperfusion of ischemic areas and in infarcted zones. However, functional sequelae of the C5b-9 complex binding to myocardial cells have not been identified. Insertion of C5b-9 complexes into the membrane of other cell types can generate transient changes in membrane permeability in the absence of cell lysis. We demonstrate in beating isolated adult guinea pig and rat cardiac myocytes that human derived C5b-9 can transiently augment in a dose-dependent manner both basal cytosolic calcium concentration and calcium transients, resulting in a temporary increase in contractility. If similar changes occur in human heart cells in vivo, they could significantly affect myocardial performance and contribute to functional abnormalities seen in ischemia and other pathological conditions associated with complement activation.


This article has been cited by other articles:


Home page
 Ann. Thorac. Surg.Home page
H. L. Lazar, Y. Bao, S. Rivers, and S. A. Bernard
Pretreatment with angiotensin-converting enzyme inhibitors attenuates ischemia-reperfusion injury
Ann. Thorac. Surg., May 1, 2002; 73(5): 1522 - 1527.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
P. J. Chai, R. Nassar, A. E. Oakeley, D. M. Craig, G. Quick Jr, J. Jaggers, S. P. Sanders, R. M. Ungerleider, and P. A. W. Anderson
Soluble Complement Receptor-1 Protects Heart, Lung, and Cardiac Myofilament Function From Cardiopulmonary Bypass Damage
Circulation, February 8, 2000; 101(5): 541 - 546.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
H. L. Lazar, Y. Bao, J. Gaudiani, S. Rivers, and H. Marsh
Total Complement Inhibition : An Effective Strategy to Limit Ischemic Injury During Coronary Revascularization on Cardiopulmonary Bypass
Circulation, September 28, 1999; 100(13): 1438 - 1442.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
A. P. Vakeva, A. Agah, S. A. Rollins, L. A. Matis, L. Li, and G. L. Stahl
Myocardial Infarction and Apoptosis After Myocardial Ischemia and Reperfusion : Role of the Terminal Complement Components and Inhibition by Anti-C5 Therapy
Circulation, June 9, 1998; 97(22): 2259 - 2267.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online